Clinical Trials Browser

Completed × ABT751 × Clear all

NCT00436852 2019-07-17

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Phase 2 Completed

92 enrolled 17 charts

Neuroblastoma

NCT00047489 2018-10-31

Study of ABT-751 in Patients With Refractory Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasm

Hematologic Neoplasms

NCT00297089 2013-01-31

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Phase 1/2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00036959 2012-03-15

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

CNSGastrointestinalGenitourinaryGynecologicSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma

NCT00063102 2007-11-29

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Phase 2 Completed

Breast Neoplasms

NCT00073112 2007-11-29

A Study of ABT-751 in Patients With Renal Cell Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00073138 2007-11-29

A Study of ABT-751 in Patients With Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00073151 2007-11-29

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung